Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast.
- Published Article
Annals of Allergy Asthma & Immunology
- Publication Date
Jul 01, 2006
Montelukast provided significant protection against EIB as soon as 2 hours after a single oral dose, with persistent benefit up to 24 hours.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 07/03/2016 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/16892789